News Opinion Editor's Corner TCT 2016 My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway Shelley Wood November 07, 2016
News Opinion Editor's Corner TCT 2016 Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones Shelley Wood November 07, 2016
Presentation TCT 2016 Pragmatic Simple Trials and Big Data: Advantages and Caveats Presenter: Deepak L. Bhatt, Roxana Mehran, Robert A. Harrington October 31, 2016
Presentation TCT 2016 When Are Randomized Trials Not Enough, and Can Observational Data Reliably Inform Comparative Effectiveness Decisions? Presenter: Eugene H. Blackstone, Robert W. Yeh, Robert A. Harrington October 30, 2016
Presentation TCT 2016 Choice of Primary (or Co-primary) Endpoints: Efficacy, Safety, or Net Clinical Benefit in Superiority and Non-inferiority Trials Presenter: Roxana Mehran, Pascal Vranckx, Robert A. Harrington October 30, 2016
Presentation TCT 2016 Personalized Medicine Where Are We in 2016? Presenter: Robert A. Harrington, A. Michael Lincoff, Clyde W. Yancy October 30, 2016
Presentation TCT 2016 Anti-inflammatory Therapies for Atherosclerosis Presenter: Robert A. Harrington, A. Michael Lincoff, Jean-Claude Tardif October 30, 2016
Presentation TCT 2016 Heart Failure Advances (Ivabradine, ARNI, and More) Presenter: Robert A. Harrington, A. Michael Lincoff, Clyde W. Yancy October 30, 2016
Presentation TCT 2016 Diabetes Advances (SGLT-2, GLP-1, DPP4) Presenter: Robert A. Harrington, A. Michael Lincoff, Norman E. Lepor October 30, 2016
News Daily News Twitter Review Reveals Clues as to Who, When, and What Users Are Tweeting About Cardiovascular Disease Online Yael L. Maxwell September 28, 2016
News Conference News ESC 2016 N-Acetylcysteine for Myocardial Salvage in STEMI? NACIAM Trial Treads Where Many Have Flopped Before Shelley Wood August 28, 2016
News Daily News Galen Strohm Wagner, Who Helped Establish the Duke Databank for Cardiovascular Disease, Dies Age 76 Michael H. Wilson July 14, 2016
News Daily News Former FDA Staffer Says Missing Data Across Antithrombotic Trials Cast Doubt on Drug Effects Shelley Wood January 18, 2016
News Daily News Antiguo Miembro de la FDA Dice que los Datos que Faltan sobre Ensayos Antitrombóticos arrojan una Sombra sobre los Efectos del Fármaco Shelley Wood January 18, 2016
News Conference News AHA 2015 Inappropriate PCIs Slashed by Half Since First AUC Released, But Key Questions Remain Shelley Wood November 08, 2015
Presentation TCT 2015 Cangrelor IV: Transitioning to Oral ADP Antagonists Presenter: Deepak L. Bhatt, Robert A. Harrington, Harvey D. White October 15, 2015